Shaun A. Kirkpatrick
InvestorPresident, Biotechnologies at Research Corporation Technologies · Executive at DisperSol Technologies
Tucson
Find your path to Shaun
109 people in our graph share verified history with Shaun — schools, employers, funds. One of them is your warm intro.
Mary PattonunlockedShaun: together at University of Arizona (1987–1990)
Shaun: together at Research Corporation Technologies
×5Shaun: together at University of Arizona
×5Shaun: together at Johns Hopkins School of Advanced International Studies (SAIS)
About
Kirkpatrick has over 25 years of experience managing venture investments and technology development programs across oncology, inflammation, metabolic disease, neurological disorders, and biotherapeutics and life science tools. He oversees RCT's venture investments, technology development, and special licensing programs, and serves on several biomedical startup boards, including as a founding director of the Critical Path Institute.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Executive at DisperSol Technologies
Intro paths
→
In turn, Shaun can intro founders to DisperSol Technologies's investors below.
DisperSol Technologies's investors · 1
Experience
- Research Corporation Technologies, Inc.President & Board Membercurrent2004 — presentTucson, Arizona, United States
- Research Corporation Technologies, Inc.Vice President2001 — 2003Tucson, Arizona, United States
- Research Corporation Technologies, Inc.Director1999 — 2000Tucson, Arizona, United States
- Research Corporation Technologies, Inc.Associate1993 — 1998Tucson, Arizona, United States
- AustinPx, Pharmaceutics and ManufacturingChairmancurrent2014 — presentAustin, Texas Metropolitan Area
- Translational Drug Development (TD2)Chairmancurrent2020 — presentScottsdale, Arizona, United States
- Pheon TherapeuticsBoard Membercurrent2015 — presentLondon Area, United Kingdom
- Particle DynamicsBoard Membercurrent2021 — presentSt. Louis City County, Missouri, United States
- Critical Path Institute (C-Path)Board Membercurrent2005 — presentTucson, Arizona, United States
- Flinn FoundationBoard Membercurrent2008 — presentPhoenix, Arizona, United States
- Thomas R. Brown FoundationsBoard Membercurrent2015 — presentTucson, Arizona, United States
- Cylene PharmaceuticalsBoard Member2005 — 2010San Diego County, California, United States
- APT PharmaceuticalsBoard Member2005 — 2007Burlingame, California, United States
- Alimmune, LLCBoard Member2001 — 2007Tucson, Arizona, United States
- Therapeutic Human Polyclonals, Inc.Chairman2000 — 2007Sunnyvale, California, United States
Investments
Board seats
Alimmune LLCAPT Pharmaceuticals Inc.AustinPx™, LLCCodis™Cylene Pharmaceuticals Inc.Imagine Pharmaceuticals Inc.Pheon TherapeuticsProlifia Inc.Sertoli Technologies, Inc.Therapeutic Human Polyclonals Inc.Translational Drug Development, LLC
Per the firm's website.
Colleagues at Research Corporation Technologies
Avi Roop
Managing Director at Research Corporation Technologies
Brad Morie
Senior Director, Biotechnologies at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies
Frequently asked questions
- Who is Shaun A. Kirkpatrick?
- Kirkpatrick has over 25 years of experience managing venture investments and technology development programs across oncology, inflammation, metabolic disease, neurological disorders, and biotherapeutics and life science tools. He oversees RCT's venture investments, technology development, and special licensing programs, and serves on several biomedical startup boards, including as a founding director of the Critical Path Institute.
- Where does Shaun A. Kirkpatrick work?
- Shaun A. Kirkpatrick is President, Biotechnologies at Research Corporation Technologies and Executive at DisperSol Technologies.
- What does Shaun A. Kirkpatrick invest in?
- Shaun A. Kirkpatrick invests in Biotech, Healthtech, Medical Devices.
- What boards does Shaun A. Kirkpatrick sit on?
- Shaun A. Kirkpatrick holds tracked board seats at Alimmune LLC, APT Pharmaceuticals Inc., AustinPx™, LLC, Codis™, Cylene Pharmaceuticals Inc., Imagine Pharmaceuticals Inc., Pheon Therapeutics, Prolifia Inc., Sertoli Technologies, Inc., Therapeutic Human Polyclonals Inc..
- Where did Shaun A. Kirkpatrick go to school?
- Shaun A. Kirkpatrick studied at Johns Hopkins School of Advanced International Studies (SAIS) (Master's degree, International Economics and and Science/Technology in International Relations); University of Arizona (Bachelor's degree, Biology and Economics).
Same school
Also attended Johns Hopkins School of Advanced International Studies (SAIS)66
Jessica (Bartos) ThomasPartner at Notion CapitalStephanie KomsaVice President – Institutional Client Relations, ATEL Capital Group at ATEL VenturesKayla RenzChief of Staff at First Row PartnersAshley N. PattonSr. Stewardship Analyst at Sands Capital VenturesJanna AyoubChief of Staff at C5 CapitalChristian SiegeleManaging Partner at Capnamic
+ 60 more
Also attended University of Arizona199
Benjamin BrockwellVenture Partner at Copper Sky CapitalMary PattonScientific Advisory Board at InnoCom Bio EquitiesTom KalinskeInvestor at Alsop Louie PartnersEmily FritzePartner at The Westly GroupPhil WickhamExecutive Managing Director at Sozo VenturesDeena RidleyChief Financial Officer at PEARL ENERGY INVESTMENTS
+ 193 more
